Work

A Phase II Trial of Sunitinib (SU11248) in Multiple Myeloma.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.4954.4954

Authors: Shaji Kumar, Patrick J. Flynn, Wee Joo J Chng, Kenny Ieng Kit Lei, Jacob Allred, Kristina Laumann, Kevin Webster, Morie A Gertz, Angela Dispenzieri, Philip R. Greipp, Suzanne R. Hayman, Steven R. Zeldenrust, Charles Erlichman, S. Vincent Rajkumar, Martha Q. Lacy

Institutions: Mayo Clinic, Minnesota Oncology, National University Hospital, Prince of Wales Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980235462

FWCI:

Cites:

Cited by: 7

Related to: 10